Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05786001
Other study ID # R20156L
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date April 1, 2023
Est. completion date February 1, 2024

Study information

Verified date March 2023
Source Tampere University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Assessment of a novel diagnostic method for screening and diagnosing chronic limb-threatening ischemia (CLTI). Using hyperspectral and thermal imaging, the perfusion and oxygenation in the lower limbs will be studied in healthy and unhealthy individuals.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 150
Est. completion date February 1, 2024
Est. primary completion date April 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - for CLTI patients age >50 - for age control group age >50 and not diagnosed with cardiovascular diseases. 0.9 < ABI < 1.3 - for healthy group 18 <= age <= 50 and no history of cardiovascular disease - volunteering for study Exclusion Criteria: - inability to give informed consent - denial

Study Design


Related Conditions & MeSH terms

  • Chronic Limb Threatening Ischemia
  • Ischemia

Locations

Country Name City State
Finland Tampere University Tampere Pirkanmaa

Sponsors (2)

Lead Sponsor Collaborator
Tampere University Tampere University Hospital

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Perfusion in lower limb angiosomes assessed by thermal imaging Thermal imaging will be used to assess the perfusion in the lower limbs. The lower limb can be divided into six angiosomes, which can then be used to assess thermal patterns. Healthy and unhealthy feet will present with different thermal patterns and other changes in thermographs. 45 minutes during the procedure starting from the first measurement and ending after the last measurement
Primary Oxygenation in lower limb angiosomes assessed by hyperspectral imaging. Hyperspectral imaging can be used in the assessment of oxygenation in the lower limb angiosomes. Based on hyperspectral imaging, oxygenation maps can be generated and then analyzed. Differences between the oxygenation maps of healthy and unhealthy patients will be established. 45 minutes during the procedure starting from the first measurement and ending after the last measurement
See also
  Status Clinical Trial Phase
Recruiting NCT04267640 - Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers Phase 2
Completed NCT05659004 - Referrals for CLTI: Qualitative Study
Recruiting NCT05553509 - Clinical Outcomes Following Surgical Debridement of Diabetic Foot Infection With Borderline Vascularity
Not yet recruiting NCT05613907 - Can a Dedicated Chronic Limb-threatening Ischaemia (CLTI) Clinic Improve Patient Self-reported Quality of Life
Recruiting NCT05620095 - Durg Coated Balloon Angioplasty in Infrapopliteal Lesions